American Portfolios Advisors Cyma Bay Therapeutics, Inc. Transaction History

American Portfolios Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Mar 22, 2023	BUY	$4.23 - $6.55 $1,480 - $2,292	350 New	350 $1.59 Million
Q4 2020 Mar 22, 2023	BUY	$5.73 - $9.03 $2,005 - $3,160	350 New	350 $2.01 Million
Q3 2020 Mar 22, 2023	BUY	$3.32 - $7.24 $1,162 - $2,534	350 New	350 $2.53 Million
Q1 2020 Mar 24, 2023	BUY	$1.25 - $2.02 $437 - $707	350 New	350 $518,000
Q4 2019 Mar 24, 2023	BUY	$1.33 - $5.93 $465 - $2,075	350 New	350 $686,000
Q2 2019 Mar 24, 2023	BUY	$6.05 - $13.66 $4,416 - $9,971	730 New	730 $5.23 Million
Q4 2018 Mar 24, 2023	BUY	$6.54 - $11.74 $2,289 - $4,109	350 New	350 $2.76 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.